Global Intra-Uterine Contraceptive Devices Market: Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

  • ID: 4432560
  • Report
  • Region: Global
  • 171 pages
  • Data Bridge Market Research Private Limited
1 of 4
The Market of Global Intra-Uterine Contraceptive Devices Market is accounted to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016,it is growing at a CAGR of 3.5% in the forecast period 2017 to 2024

FEATURED COMPANIES

  • AME Line
  • Bernstein Leibhard LLP
  • Cepeo
  • Contraceptivos
  • Egemen International
  • Medu Scientific Ltd
  • MORE
The Market of Global Intra-Uterine Contraceptive Devices Market is accounted to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, it is growing at a CAGR of 3.5% in the forecast period 2017 to 2024.

The major factors driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancements and favourable insurance for IUCD’s.

The key market players for Global Intra-Uterine Contraceptive Devices Market are listed below:
  • Teva Pharmaceuticals Industries Ltd.
  • Mona Lisa N.V.
  • DKT International
  • Egemen International
  • Melbea AG
  • Ocon Medical Ltd.
  • Pregna International Limited
  • Medical Engineering Corporation SA
  • SMB Corporation
  • Meril Life Sciences Pvt. Ltd.
  • Medu Scientific Ltd
  • China RH Contraceptives Co., Ltd
  • Sanghai Jolly Medical Education Co., Ltd
  • Bernstein Leibhard LLP
  • ZheijangDaji Medical Instruments, Ltd.
  • Nimble International
  • AME Line
  • Technico
  • Cepeo
  • Contraceptivos
  • InjeflexInd
  • Com Ltda
  • Bersil
  • Amed
The market is further segmented into:
  • Product Type
  • End User
  • Geography
The Global Intra-Uterine Contraceptive Devices Market is segmented on the basis of product type, end user, and geography.

The global intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

Based on geography, the Global Intra-Uterine Contraceptive Devices market is segmented into 11 geographical regions, such as:
  • North America
  • South America
  • Europe
  • APAC
  • MEA
Covered in this Report

The report covers the present scenario and the growth prospects of the Global Intra-Uterine Contraceptive Devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of an analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AME Line
  • Bernstein Leibhard LLP
  • Cepeo
  • Contraceptivos
  • Egemen International
  • Medu Scientific Ltd
  • MORE
1 Introduction
1.1. Overview of the Global Intra-Uterine Contraceptive Delivery Market
1.2. Currency and Pricing
1.3. Limitation
1.4. Markets Covered

2 Market Segmentation
2.1. Key Takeaways
2.2. Arriving at the Global Intra-Uterine Contraceptive Delivery Market Size
2.2.1 Vendor Positioning Grid
2.2.2 Technology Life Line Curve
2.2.3 Market Time Line
2.2.4 Market Guide
2.2.5 Company Positioning Grid
2.2.6 Comapany Market Share Analysis
2.2.7 Multivariate Modelling
2.2.8 Standards of Measurement
2.2.9 Top to Bottom Analysis
2.2.10 Vendor Share Analysis
2.2.11 Data Points from Key Primary Interviews
2.2.12 Data Points from Key Secondary Databases
2.3. Global Intra-Uterine Contraceptive Delivery Market: Research Snapshot
2.4. Assumptions

3 Market Overview
3.1. Drivers
3.2. Restraints
3.3. Opportunities
3.4. Challenges

4 Executive Summary

5 Premium Insights
5.1. Vendor Positioning Grid and Investment Opportunities
5.2. Technololgical Advancements
5.3. Insights on Technological Developments in the Global Intra-Uterine Contraceptive Delivery Market
5.4. Market Regulatory Scenario by Country
5.5. Interview Key Insights

6 Global Intra-Uterine Contraceptive Delivery Market: by Type

7 Global Intra-Uterine Contraceptive Delivery Market: by Product Type

8 Global Intra-Uterine Contraceptive Delivery Market: by Application

9 Global Intra-Uterine Contraceptive Delivery Market: by End User

10 Global Intra-Uterine Contraceptive Delivery Market: Geography

11 Global Intra-Uterine Contraceptive Delivery Market: Company Profiles
11.1 Teva Pharmaceuticals Industries Ltd.
11.2 Mona Lisa N. V.
11.3Mona Lisa N. V.
11.4 Egemen International
11.5 Melbea Ag
11.6 Company a
11.7 Company B
11.8 Company C
11.9 Company D
11.10 Company E
11.11 Company F
11.12 Company G
11.13 Company H
11.14 Company I
11.15 Company J
11.16 Company K
11.17 Company M
11.18 Company N
11.19 Company O

12 Appendix

13 About Us
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Teva Pharmaceuticals Industries Ltd.
  • Mona Lisa N.V.
  • DKT International
  • Egemen International
  • Melbea AG
  • Ocon Medical Ltd.
  • Pregna International Limited
  • Medical Engineering Corporation SA
  • SMB Corporation
  • Meril Life Sciences Pvt. Ltd.
  • Medu Scientific Ltd
  • China RH Contraceptives Co. Ltd
  • Sanghai Jolly Medical Education Co. Ltd
  • Bernstein Leibhard LLP
  • ZheijangDaji Medical Instruments Ltd.
  • Nimble International
  • AME Line
  • Technico
  • Cepeo
  • Contraceptivos
  • InjeflexInd
  • Com Ltda
  • Bersil
  • Amed
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll